Circulating Anti-Sorting Nexins 16 Antibodies as an Emerging Biomarker of Coronary Artery Disease in Patients with Obstructive Sleep Apnea
出版年份 2020 全文链接
标题
Circulating Anti-Sorting Nexins 16 Antibodies as an Emerging Biomarker of Coronary Artery Disease in Patients with Obstructive Sleep Apnea
作者
关键词
-
出版物
Diagnostics
Volume 10, Issue 2, Pages 71
出版商
MDPI AG
发表日期
2020-01-28
DOI
10.3390/diagnostics10020071
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Strategies to augment adherence in the management of sleep‐disordered breathing
- (2019) Bernie Y. Sunwoo et al. RESPIROLOGY
- Obstructive sleep apnoea in acute coronary syndrome
- (2019) Winfried Randerath et al. European Respiratory Review
- Circulating autoantibodies against neuroblastoma suppressor of tumorigenicity 1 (NBL1): A potential biomarker for coronary artery disease in patients with obstructive sleep apnea
- (2018) Takuma Matsumura et al. PLoS One
- Oxidized LDL and anti-oxidized LDL antibodies in atherosclerosis – Novel insights and future directions in diagnosis and therapy ,
- (2018) Adam Hartley et al. TRENDS IN CARDIOVASCULAR MEDICINE
- Obstructive sleep apnoea and coronary artery disease
- (2018) Swapna Mandal et al. Journal of Thoracic Disease
- Circulating Anti-Coatomer Protein Complex Subunit Epsilon (COPE) Autoantibodies as a Potential Biomarker for Cardiovascular and Cerebrovascular Events in Patients with Obstructive Sleep Apnea
- (2017) Takuma Matsumura et al. Journal of Clinical Sleep Medicine
- Inhibition of epidermal growth factor receptor attenuates atherosclerosis via decreasing inflammation and oxidative stress
- (2017) Lintao Wang et al. Scientific Reports
- Heat shock protein 70 and antibodies to heat shock protein 60 are associated with cerebrovascular atherosclerosis
- (2016) Ružica Galović et al. CLINICAL BIOCHEMISTRY
- Impact of Obstructive Sleep Apnea on the Levels of Placental Growth Factor (PlGF) and Their Value for Predicting Short-Term Adverse Outcomes in Patients with Acute Coronary Syndrome
- (2016) Antonia Barcelo et al. PLoS One
- Usefulness of Fetuin-A to Predict Risk for Cardiovascular Disease Among Patients With Obstructive Sleep Apnea
- (2015) Alice Liu et al. AMERICAN JOURNAL OF CARDIOLOGY
- THU0029 Identification of Cerebral Infarction-Specific Antibody Markers from Autoantibodies Detected in Patients with Systemic Lupus Erythematosus
- (2015) K.-I. Goto et al. ANNALS OF THE RHEUMATIC DISEASES
- Identification of stroke-associated-antigens via screening of recombinant proteins from the human expression cDNA library (SEREX)
- (2015) Toshio Machida et al. Journal of Translational Medicine
- Oxidized low-density lipoprotein as a biomarker of cardiovascular diseases
- (2014) Andreja Trpkovic et al. CRITICAL REVIEWS IN CLINICAL LABORATORY SCIENCES
- Effect of CPAP Treatment for Obstructive Sleep Apnea Hypopnea Syndrome on Lipid Profile: A Meta-Regression Analysis
- (2014) Rashid Nadeem et al. Journal of Clinical Sleep Medicine
- Mechanism of sudden cardiac death in obstructive sleep apnea, revisited
- (2014) A. Chan et al. SLEEP MEDICINE
- Effect of CPAP on Blood Pressure in Patients With OSA/Hypopnea
- (2013) Cristiano Fava et al. CHEST
- Cardiovascular mortality in obstructive sleep apnoea treated with continuous positive airway pressure or oral appliance: An observational study
- (2013) Anil Anandam et al. RESPIROLOGY
- Obstructive Sleep Apnea
- (2011) Luciano F. Drager et al. CHEST
- Role of SNX16 in the Dynamics of Tubulo-Cisternal Membrane Domains of Late Endosomes
- (2011) Ben Brankatschk et al. PLoS One
- Obstructive sleep apnea, immuno-inflammation, and atherosclerosis
- (2009) Claire Arnaud et al. Seminars in Immunopathology
- Sleep Apnea and Cardiovascular Disease
- (2008) Virend K. Somers et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now